Durolane injection and Insulin glargine and lixisenatide Subcutaneous
Determining the interaction of Durolane injection and Insulin glargine and lixisenatide Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: sodium hyaluronate
Brand name: Durolane, Euflexxa, Gel-One, Gelsyn-3, Hyalgan, Supartz, Supartz FX, Visco-3, Trivisc, GenVisc 850, Monovisc, Orthovisc, Synvisc, Synvisc-One
Synonyms: Durolane (injection)
Generic Name: insulin glargine / lixisenatide
Brand name: Soliqua 100/33
Synonyms: Insulin glargine and lixisenatide (Subcutaneous)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Durolane injection-Insulin glargine, recombinant Subcutaneous
- Durolane injection-Insulin glulisine
- Durolane injection-Insulin Glulisine (Cartridges and Pens)
- Durolane injection-Insulin Glulisine (Vials)
- Durolane injection-Insulin glulisine Subcutaneous
- Durolane injection-Insulin human inhaled Inhalation
- Insulin glargine and lixisenatide Subcutaneous-Durvalumab
- Insulin glargine and lixisenatide Subcutaneous-Durvalumab Intravenous
- Insulin glargine and lixisenatide Subcutaneous-Dutasteride
- Insulin glargine and lixisenatide Subcutaneous-Dutasteride and tamsulosin
- Insulin glargine and lixisenatide Subcutaneous-Dutasteride and Tamsulosin Capsules
- Insulin glargine and lixisenatide Subcutaneous-Dutasteride Capsules